A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.
Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.
Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...
The Biden administration has added popular weight loss and diabetes drugs, including Ozempic and Wegovy, to Medicare’s list ...
Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.
The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...
Biden administration selects 15 new medications up for price negotiations including weight loss drugs Ozempic and Wegovy.
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...
The drugs account for $41 billion in annual Medicare spending, the Biden administration said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback